MMedication Read More How GLP-1s are more than just weight-loss wonders – but not without riskMay 23, 2026 Not long ago, nobody was talking about GLP-1 receptor agonists. Most of us did not even know what…
MMedication Read More Controversial FDA official leaving drug center post in latest departure at agencyMay 16, 2026 The leader of the Food and Drug Administration division responsible for regulating prescription and over-the-counter drugs is leaving…
HHealth care Read More FDA Blocked Melanoma Drug as Confusion Reigned Under MakaryMay 15, 2026 The FDA’s recent decision to withhold approval of a new skin cancer treatment fell like a hammer on…
NNutrition Read More ‘Sugar Free’ & ‘No Sugar Added’ Aren’t The Same Thing—A Dietitian Explains The DifferenceMay 11, 2026 With increased scrutiny of ultra-processed foods, people are reading nutrition labels more closely than ever before. Brands are…
MMedication Read More Rulli bill would ease regulation of thyroid medication | Local NewsMay 9, 2026 Valley Congressman Michael Rulli has introduced federal legislation aimed at ensuring patients can continue to access certain thyroid…
HHealth care Read More Credit HHS for a host of new steps that’ll boost public health — and save livesMay 9, 2026 For all our concerns over Robert Kennedy Jr.’s leadership, his Health and Human Services Department is advancing several…
MMedication Read More FDA Resubmission Path for Tab-cel Keeps Atara’s (ATRA) Regulatory Timeline AliveMay 7, 2026 medical research 7 ©Belova59 – pixabay.com Atara Biotherapeutics said the FDA outlined a potential pathway for resubmitting the…
MMedication Read More Does FDA’s Rolling Review Of COMP360 Psilocybin Depression Therapy Change The Bull Case For COMPASS Pathways (CMPS)?May 5, 2026 In April 2026, COMPASS Pathways announced that the FDA granted a rolling NDA review for its synthetic psilocybin…
HHealth Read More Brain-Zapping Device OK’d by FDA May Offer SSRI AlternativeApril 29, 2026 A small headset that delivers weak electrical currents to the brain is being pitched as a new…
MMedication Read More Can Oral Ozempic and Label Expansions Revive NVO’s Near-Term Growth?April 29, 2026 Novo Nordisk NVO is a dominant player in the GLP-1 space, marketing its semaglutide drugs under brand names Ozempic…
BBusiness Read More FDA testing speedier drug development with real-time clinical trialsApril 29, 2026 WASHINGTON — The Food and Drug Administration on Tuesday announced efforts to make clinical trials more efficient, starting…
HHealth care Read More Wait, So Are Peptides Legal Now?April 26, 2026 Wait, So Are Peptides Legal Now?drasa – Getty Images “Hearst Magazines and Yahoo may earn commission or revenue…